biocryst is terminating bcx5191 program, page-15

Hi Esc, I disagree re PC's antibiotics purchase.

He bought it at the bottom of the market (for antibiotics) and when our share price was strong. Most of the purchase was through shares.

His purchase has somewhat been validated with NIH funding for one of those programs.

I think antibiotics will be huge area of interest in the next few years....and we entered at the ground level.

It's like how Clive Palmer bought up all the cheap coal leases many years ago when you couldn't give them away....